• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

ALS/MND Connect

ALS/MND Connect is an open session which allows people living with ALS/MND and their caregivers to virtually attend an afternoon of presentations by neurologists and researchers. This session is live-streamed on our Facebook channel, so people with ALS/MND from around the world can attend and ask questions online.

Date: November 30, 2025
Time: 2 pm – 3 pm ET
Location: International Alliance Facebook channel

2025 Host Associations

 

Primary Sidebar

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Alex, Argentina

    Alex, Argentina

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Amparo Muriel Engativa, Colombia

    Amparo Muriel Engativa, Colombia

  • Hans Dieter Olszewski, Germany

    Hans Dieter Olszewski, Germany

  • Irene McCaughey, Australia

    Irene McCaughey, Australia

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Jorge Luis Fernández Romero, Mexico

    Jorge Luis Fernández Romero, Mexico

  • Chih Ching Darren Wong, Malaysia

    Chih Ching Darren Wong, Malaysia

  • Inta Grubb, Australia

    Inta Grubb, Australia

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Marcel R. Wernard, Netherlands

    Marcel R. Wernard, Netherlands

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Animesh Kumar, India

    Animesh Kumar, India

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Anna Barrow, UK

    Anna Barrow, UK

  • Susan Anderson, USA

    Susan Anderson, USA

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • Luis Antonio Pimenta Lima, Brazil

    Luis Antonio Pimenta Lima, Brazil

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Mike Cels, Canada

    Mike Cels, Canada

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Verónica Isabel Castro Molina, Argentina

    Verónica Isabel Castro Molina, Argentina

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Frank Taylor, USA

    Frank Taylor, USA

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Nicholas (Nic) Bowman, South Africa

    Nicholas (Nic) Bowman, South Africa

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Jon Newsome, USA

    Jon Newsome, USA

  • Oscar Mauricio Linares, Colombia

    Oscar Mauricio Linares, Colombia

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Orly Dichoso, Canada

    Orly Dichoso, Canada

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login